CORRECTING and REPLACING JFrog to Present at Upcoming Investor Conferences
SUNNYVALE, Calif.–(BUSINESS WIRE)–$FROG #AI–Second bullet of release should read: Canaccord Genuity Growth Conference in Boston, Massachusetts,... Read more.
Atkore Inc. Declares Quarterly Dividend
HARVEY, Ill.–(BUSINESS WIRE)–The Board of Directors of Atkore Inc. (the “Company”) (NYSE: ATKR), a leading manufacturer of electrical products for... Read more.
FuriosaAI Closes $125M Investment Round to Scale Production of Next-Gen AI Inference Chip
SEOUL, South Korea–(BUSINESS WIRE)–FuriosaAI, a semiconductor company building a new foundation for AI compute, today announced it has completed a $125... Read more.
Columbia Sportswear Company Releases 2024 Impact Report
PORTLAND, Ore.–(BUSINESS WIRE)–Columbia Sportswear Company (NASDAQ: COLM), a global leader in outdoor, active, and lifestyle products, today published... Read more.
Allstate Reports Second Quarter 2025 Results
NORTHBROOK, Ill.–(BUSINESS WIRE)–The Allstate Corporation (NYSE: ALL) today reported financial results for the second quarter of 2025. “Allstate had... Read more.
Prime Healthcare Achieves National Recognition for Exemplary Social Responsibility by Lown Institute
Prime Healthcare hospitals lead the nation in patient care, community service, health equity, and exceptional outcomes ONTARIO, Calif.–(BUSINESS WIRE)–Prime... Read more.
Cactus Announces Second Quarter 2025 Results
HOUSTON–(BUSINESS WIRE)–Cactus, Inc. (NYSE: WHD) (“Cactus” or the “Company”) today announced financial and operating results for the second quarter... Read more.
Babcock & Wilcox Sets Second Quarter 2025 Conference Call and Webcast for Monday, August 11, 2025 at 5 p.m. ET
AKRON, Ohio–(BUSINESS WIRE)–$BW–Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the “Company”) will host a conference call and... Read more.
MPR Associates and High Reliability Group Form Novellum Partners LLC to Accelerate Advanced Nuclear Technology Deployment
New Consulting Firm to Drive Innovation and Transformational Success in Critical Energy and Infrastructure Projects ALEXANDRIA, Va.–(BUSINESS WIRE)–MPR... Read more.
AQNEURSA® (levacetylleucine) Recommended for EU Approval by the CHMP to Treat Niemann-Pick Disease Type C
AQNEURSA® could offer a new frontline treatment for NPC patients in Europe CHMP recommendation based on Phase III pivotal trial data and extension phase data, showing... Read more.